FDA Variance Approval Letter for Alexander Kulik
Summary
The FDA has issued a variance approval letter to Alexander Kulik, as posted on March 20, 2026. The letter, issued by the Center for Devices and Radiological Health (CDRH), pertains to a specific variance request.
What changed
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Alexander Kulik. The document, dated March 20, 2026, indicates that a specific variance request has been approved. Due to the restricted nature of the information, only a redacted version of the letter is publicly available.
This approval signifies that a specific deviation from standard FDA regulations has been granted for the named individual or entity. Compliance officers should note that while this is an individual approval, it may set a precedent or provide insight into the FDA's considerations for similar variance requests in the future, particularly concerning medical devices or pharmaceuticals.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 2
Variance Approval Letter to Alexander Kulik
Restricted: Personally Identifiable Information
More Information
- Author(s) CDRH
Variance Approval Letter to Alexander Kulik_Redacted
More Information
- Author(s) CDRH
Download
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.